TCT-80 The Everolimus-Eluting Synergy Megatron Drug-Eluting Stent Platform for Aorto-Ostial and Proximal Coronary Disease: Early Outcomes From the European Synergy Megatron Implanters’ Registry

Kam Wa, M. L., de Silva, K., Wells, T., Mozid, A., Ladwiniec, A., Hynes, B. G., Kotecha, A., Ratib, K., Biswas, S., Amabile, N., Deharo, P., McEntegart, M., Spratt, J., Digne, F., Hogg, M., Mailey, J., Walsh, S., & Kalra, S. (2023). TCT-80 The Everolimus-Eluting Synergy Megatron Drug-Eluting Stent Platform for Aorto-Ostial and Proximal Coronary Disease: Early Outcomes From the European Synergy Megatron Implanters’ Registry. Journal of the American College of Cardiology, 82(17), B32. https://doi.org/10.1016/j.jacc.2023.09.085
Authors:
Matthew Li Kam Wa
Kalpa De Silva
Tim Wells
Abdul Mozid
Andrew Ladwiniec
Brian Hynes
Ash Kotecha
Karim Ratib
Sinjini Biswas
Nicolas Amabile
Pierre Deharo
Margaret McEntegart
James C. Spratt
Franck Digne
Meadhbh Hogg
Jonathan Mailey
Simon Walsh
Sundeep Kalra
Affiliated Authors:
Margaret McEntegart
Publication Type:
Article
Unique ID:
10.1016/j.jacc.2023.09.085
Publication Date:
Data Source:
OpenAlex

Record Created: